Home  »  Ipo Review  »  Infinion Biopharma Ipo

Let’s have a detailed review of the company and analytics of the Infinion Biopharma IPO release date, IPO offer price, subscription, Infinion Biopharma Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.

Face Value Rs 10
Cash Price  Rs [●]
Listing At BSE, NSE
Min. Order Quantity NA
Listing Date NA
Offer for Sale Rs Thousands
Fresh Issue Rs Thousands
IPO Size Rs Thousands
Tick Size 1

Infinion Biopharma IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.

Infinion Biopharma IPO – Summary

Infinion Biopharma IPOInfinion Biopharma is an innovation-driven life sciences company that combines biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across a range of therapeutic areas.

They have created a global scientific ecosystem with some of the best scientific minds in the world from multiple disciplines including biophysics, biochemistry, pharmacology, and biotechnology to create innovative products to manage and treat various diseases.

The Promoter of this company is GAUTAM BALI, VISHAL JAIN & GOVINDSINH CHAVADA. The lead manager to the issue is ARYAMAN FINANCIAL SERVICES LIMITED, and the Registrar to this issue is BIG SHARE SERVICES PRIVATE LIMITED.

Infinion Biopharma IPO Date

The opening and the closing date of Infinion Biopharma IPO are not available yet.

Infinion Biopharma IPO Subscription

Day / Date QIB NII RII Total Subscription
1st Day – 
2nd Day –  
3rd Day – 
Shares Offered or Net Issue

The shares subscribed by the public will be updated here.

Check Infinion Biopharma IPO LIVE Subscription

  • Infinion Biopharma IPO LIVE Bid details on BSE
  • Infinion Biopharma IPO LIVE Bid details on NSE

For the Latest Bid details click on the above links.

Infinion Biopharma IPO Allotment Status

Here, you can find the Allotment Status of this IPO.

Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.

Infinion Biopharma Limited IPO Listing Date

Find the dates below on basis of allotment, refund, listing, and more:

Basis of Allotment Finalization
Refunds Initiation
Credit of Shares to Demat Account
Share Listing Date

Infinion Biopharma IPO Cash Price

The face value of each share is Rs.10, but the price band of the IPO is Rs.[●] 

Infinion Biopharma IPO Equity Size

This Initial Public Issue of 45,00,000 Equity Shares of Rs.10 each for cash at a price of Rs.[●]  per equity share aggregating to Rs.[●] Thousands.

Infinion Biopharma IPO Share Offering

Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of [●] Equity Shares of Rs.10/ each.

Issue Size: X Equity Shares of Rs.10 each, aggregating to Rs.[●] Thousands

Open Free Demat Account Now!

    Fill Your Details Here
    1. Open Demat AccountInvest in IPO

    Infinion Biopharma IPO – Live Performance

    The listing date of this IPO is [●]. You can check the live performance of the IPO here, only after it is listed on exchanges.

    Live IPO Performance – Infinion Biopharma Share Price

    Infinion Biopharma IPO Grey Market Premium

    The Infinion Biopharma Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is X. 

    Infinion Biopharma IPO – Company Overview

    They are engaged in the business of pharmaceutical licensing and commercialization of high-value, innovative products across a range of therapeutic areas.

    Their current focus areas include (i) Formulation Technology – to enable better products for skincare and women‘s health; for this focus area they have invested in and have licensed technology from US-based Ansella Therapeutics Inc. (ii) Biotechnology – to enable better diagnostic and treatment options for neurological conditions; for this focus area, they have invested in the UK based Aurum Biosciences. (iii) Process Technology – to enable better processes to manufacture biological drugs; for this focus area they plan to partner with USbased Mobius Biomedical Inc.

    They believe they have been able to achieve favorable terms, both for purchasing licensing rights as well as for purchasing equity in the above companies, due to the strong relationships that their promoters have developed with those companies.

    In the absence of these relationships, they believe that securing licensing or investment in these highly desirable, innovative companies would have been more expensive for them or any other company in India.

    Infinion Biopharma IPO – Financial Statements

    A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:

    Financial Summary:

    Amount (in INR & Thousands)
    31-Mar-21 31-Mar-20 Mar-19
    Total Assets 1,83,000.17 86,873.38 75,849.00
    *Total Revenue 68,987.06
    Total Expense 4,742.64 13,672.86 3,633.98
    Profit After Tax 64,240.27 (13,697.46) (3,635.15)

    Earnings per Equity Share (in Thousands)

    31-Mar-21 31-Mar-20 Mar-19
    Basic & Diluted 6.24 (1.71) (0.66)


    Further, their PAT for the period ended on March 31, 2021, March 31, 2020, and March 31, 2019, were Rs. 64,240.27 Thousand, Rs. (13,697.46) Thousands and Rs. (3,635.15) Thousands respectively.

    Infinion Biopharma IPO – Promoters

    The Promoter of this company is:


    List of Related Parties (Key Managerial Personnel)

    • Gautam Bali, Chairperson, and Non-Executive Director
    • Vishal Jain, Vice-Chairperson and Non Executive Director
    • Narendrasinh Devda, Whole – Time Director
    • Govindsinh Chavada, Non-Executive Director
    • Pankaj Singh, Non- Executive Independent Director
    • Dinesh Singh, Non-Executive Independent Director

    Infinion Biopharma IPO – Promoters Holding

    • Pre Issue Share Holding – %
    • Pos Issue Share Holding – %

    Infinion Biopharma IPO Offer Details or Issue Details

     Particulars  No. Of Equity Shares
     Equity Shares Offered  Up to 45,00,000 Equity Shares aggregating up to Rs.[●] Thousands
    of which:
    Issue Reserved for the Market Makers Up to [●] Equity Shares aggregating up to Rs.[●]
    Net Issue to the Public Up to [●] Equity Shares aggregating up to Rs.[●]
    Of which:
    Retail Investors Portion Not less than [●] Equity Shares
    Other than Retail Individual Investors Not more than [●] Equity Shares
     Equity Shares outstanding prior to the Issue 1,04,50,500 Equity Shares
     Equity Shares outstanding after the Issue 1,49,50,500 Equity Shares

    Infinion Biopharma IPO Issue Object

    Their Company proposes to utilize the Net Proceeds towards funding the following objects:

    a) Investment in Mobius Biomedical Inc.
    b) Acquisition of License for product Development of Skin Care and Women‘s Health Product;
    c) Working Capital Requirements;
    d) Sales, Marketing and Distribution Expenses for setting up their geographical reach
    e) General Corporate Purposes.

    Infinion Biopharma – Business Strategy

    • Leverage their acquisition of a license for Competitive Advantage
    • Leverage their strategic investments in R&D Companies
    • Strengthen their presence in India and set up their sales and distribution network

    Infinion Biopharma IPO – Basis of Offer Price

    The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

    Qualitative factors are:

    • Experienced Promoters with Extensive Domain Knowledge
    • Global Patented Licensed Technology
    • Tie-ups with recognized manufacturing partners
    • First mover advantage
    • Their proven execution track record

    The relevant quantitative factors are:

    Basic & Diluted EPS RONW (%) NAV (Rs.)
    31-Mar-21 6.24 37.93 16.28
    31-Mar-20 (1.71) -16.59
    Mar-19 (0.66) -5.21

    Infinion IPO: Competitive Peers

    Face Value (Rs.) P/E EPS  (Rs.) Return on Net Worth (%) Total Income (Rs. in Thousands)
    Infinion Biopharma Limited 10 [●] 6.24 37.93 68,987.06
    Listed Peers

    Infinion Biopharma IPO Lead Managers

    Lead Managers
    60, Khatau Building, Ground Floor, Alkesh Dinesh Modi Marg,
    Fort, Mumbai – 400 001
    Tel: +91 – 22 – 6216 6999
    Email: ipo@afsl.co.in
    Website: www.afsl.co.in
    Investor Grievance Email: feedback@afsl.co.in
    Contact Person: Vatsal Ganatra
    SEBI Registration No.: INM000011344

    Infinion Biopharma IPO Registrar to offer

    Registrar to the Offer
    1st Floor, Bharat Tin Works Building, Makwana Road,
    Marol, Andheri East, Mumbai – 400 059
    Tel: +91 – 22 – 6263 8200;
    Email: ipo@bigshareonline.com;
    Website: www.bigshareonline.com
    Investor Grievance Email: investor@bigshareonline.com;
    Contact Person: Ashish Bhope
    SEBI Registration No.: INR000001385

    Infinion IPO – Other Details

    • Statutory Auditor – M/s Mahendra N Shah & Co, Chartered Accountants
    • Legal Counsel to the Company – M/S. KANGA & COMPANY (ADVOCATES & SOLICITORS)
    • Bankers to the Company –  NA

    Infinion Biopharma IPO Review by Stock Brokers

    Top Stock Brokers Review Company Reputation Competitive Edge Financial Statement Popularity Index Promoters Reputation
    Angel Broking 7.5/10 7.4/10 8.5/10 8.1/10 7.1/10
    Sharekhan 7.2/10 7.1/10 8.6/10 8.1/10 7.2/10
    Kotak Securities 7.3/10 7.5/10 8.4/10 8.1/10 7.3/10
    ICICI Direct 7.3/10 7.3/10 8.7/10 8.1/10 7.1/10
    IIFL 7.5/10 7.2/10 8.8/10 8.0/10 7.1/10
    Edelweiss 7.5/10 7.4/10 8.4/10 8.3/10 7.2/10
    Zerodha 7.4/10 7.1/10 8.5/10 8.1/10 7.0/10
    5Paisa 7.1/10 7.1/10 8.4/10 8.1/10 7.1/10
    Karvy 7.4/10 7.3/10 8.2/10 8.1/10 7.1/10
    Motilal Oswal 7.1/10 7.1/10 8.6/10 8.3/10 7.2/10


    Subscribe to Infinion Biopharma IPO

      Fill Your Details Here
      1. Open Demat AccountInvest in IPO

      Infinion Biopharma Limited IPO News

      News 1 – IPO DRHP Download

      News 2 – IPO RHP Prospectus Download

      Infinion Biopharma IPO Review FAQs

      Ques – What is the Issue Size of Infinion Biopharma IPO?

      Answer – The Company is making an initial public offer of 45,00,000 equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.

      Ques – What is the Price band of Infinion Biopharma IPO?

      Answer – The price band for this particular IPO ranges between NA. As far as the face value of the share is of concern, it is Rs.10 per share.

      Ques – What is the Infinion Biopharma IPO Open Date?

      Answer – The opening and closing dates for this IPO have been updated. The IPO is set to open on NA, while the closing date is set at NA.

      Ques – What is the Infinion IPO Allotment Date?

      Answer – They also have the news regarding the respective allotment dates of this IPO. Basis of Allotment finalization is on NA, refund initiation is on NA, credit of shares is on NA, and share listing date is on NA.

      Ques – What is the Infinion Biopharma IPO Listing Date?

      Answer – Shares of this company shall be listed in the exchanges NA. The date, when the listing would be done, is stagnant on NA.

      Ques – Who is the Registrar of Infinion IPO?

      Answer – One of the reputed registrars is managing the issue of this IPO, i.e. Bigshare Services Private Limited. Their website will help you regarding the further information you are on the lookout for.

      Ques – Who is the Promoter of Infinion Biopharma IPO?

      Answer – Here are the promoters of this IPO – GAUTAM BALI, VISHAL JAIN & GOVINDSINH CHAVADA. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.

      Ques – What is the GMP of Infinion Biopharma IPO?

      Answer – They have obtained the GMP of this IPO and it is NA. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.

      Ques – Is Infinion Biopharma IPO good for Investment?

      Answer – They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.

      Ques – What is the PAT of Infinion Biopharma Company?

      Answer – They have the information of company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2021 in Thousands is 64,240.27, 2020 is (13,697.46), 2019 is (3,635.15).

      Calculate your return on investment!

      Asset Class ROI (Rs.) Profit (Rs.) Profit (%)
      Real Estate
      Fixed Deposit
      Mutual Fund

      Featured Topics


      Get 100% IPO Allotment Guarantee! Subscribe to IPO